Basic & Translational Research

The path to truly effective AMD therapies is long and requires us to recognize that it’s not a single disease entity: toil and teamwork are needed to triumph

Sitting Down With...Patricia A. D’Amore, Director, Howe Laboratory; Director of Research, Schepens EyeResearch Institute, and Charles L. Schepens Professor of Ophthalmology, Harvard Medical School, Massachusetts, USA.

Can the combination of 360° haptics and a novel protective membrane, which emulates the pattern found on shark skin, in a single IOL prevent PCO and make YAG laser capsulotomies a thing of the past?

Sitting Down With… Joan Miller, Chief and Chair of the Department of Ophthalmology, Massachusetts Eye and Ear, Mass General Hospital and Harvard Medical School

Stem cell therapies may be the future of treating retinal disease, but how do you choose the best source?

Unicellular planktonic organisms have evolved a complex eye-like structure by repurposing organelles within the cell

A protein involved in autophagy, DRAM2, appears to be essential for photoreceptor survival

A simple, clean and elegant gene editing technique might not be that simple, clean or elegant.

Gene and stem cell therapies hold the promise of restoring vision in patients with retinal diseases – but who should be paying for these treatments, and how?

Second corneal transplants are far more likely to be rejected than first-time grafts – but now that we know why, we might be able to prevent it